2Hunstad D A, Norton TA. Management of pancreatic carcinoma. Surg Ooncol, 1995,4(2):61.
3Malmud L S. Lines from the president :expanding the therapeutic applications of nuclear medicine . J Nud Med, 1992,33(1 ) :31N.
4Marano P, et al. Digagnostic and therapeutic integration in ductal carcinoma of the pancreas . Preliminary note . Radiol Med .(Torino) 1993,85(5):615.
4Norbert B,Andrea S,Ulrich G,et al.Human Tissue Responses to Metal Stents Implanted in Vivo for the Palliation of Malignant Stenoses[J].Gastrointestinal Endoscopy,1996,43 (6):596-602.
5Fletcher M,Brinkley D,Dawson J,et al.Treatment of High Bile Duct Carcinoma by Radiotherapy with Iridium-192 Wire Lancet[J].1981,2(8239):172-174.
6Leung JT,Kuan R.Intraluminal Brachytherapy in the Treatment of Bile Duct Carcinomas[J].Australas Radiol,1997,41 (2):151-154.
7Bruha R,Petrtyl J,Kubecova M,et al.Intraluminal Brachytherapy and Selfexpandable Stents in Nonresectable Biliary Malignancies the Question of Long Term Palliation[J].Hepato-Gastroenterology,2001,48(39):637-637.
9Mohiuddin M,Rosato F,Barbot D,et al.Long-term Results of Combined Modality Treatment with I-125 Implantation for Carcinoma of the Pancreas[J].Int J Radiat Oneol Biol Phys,1992,23(2):305-311.
10Gunven P,Gorsetman D,Ohlsen H,et al.Six-year Recurrence Free Survival after Intraluminal Iridium-192 Therapy of Human Bilo-bar Biliary Papillomatosis:A Case Report[J].Cancer,2000,89(1):69-73.
